Susan Wyrick
Fortuna: 614 093 $ al 31/07/2026
Fortuna: 614 093 $ al 31/07/2026
Ms. Susan D.
Wyrick, CPA, is a Senior Vice President-Finance & Accounting at Sana Biotechnology, Inc. Ms. Wyrick was previously employed as a Vice President & Controller by Juno Therapeutics, Inc. and a Chief Accounting Officer & Vice President-Finance by OncoGenex Pharmaceuticals, Inc. She received her undergraduate degree from the University of Washington.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SANA BIOTECHNOLOGY, INC. 0,08 % | 09/03/2026 | 196.196 ( 0,08 % ) | 614 093 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Comptroller/Controller/Auditor | 04/10/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| JUNO THERAPEUTICS INC | Comptroller/Controller/Auditor | 01/10/2018 |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Comptroller/Controller/Auditor | 11/06/2014 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Health Technology |
Juno Therapeutics, Inc.
Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Sana Biotechnology, Inc.
Sana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.